ERAZABAN 100 mg/g, cream tube, 2 g
Active ingredients: Docosanol
Commercialized according to BDPM
Creamtube, 2 gcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ERAZABAN 100 mg/g, crème
- Pharmaceutical form
- crème
- Route of administration
- cutanée
- Presentation description
- 1 tube(s) aluminium verni de 2 g
- Marketing authorisation holder
- PHOENIX HEALTHCARE (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Jun 2010
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66326694CIP73804153CIP133400938041538Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DOCOSANOLcrème | 100 mg · 1 g de crème | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.